Cas no 1565477-99-7 (2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde)
2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- EN300-725625
- 2-[methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde
- 1565477-99-7
- 5-Pyrimidinecarboxaldehyde, 2-[methyl(1-methylethyl)amino]-
- 2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde
-
- Inchi: 1S/C9H13N3O/c1-7(2)12(3)9-10-4-8(6-13)5-11-9/h4-7H,1-3H3
- InChI Key: NTRHGFHYPOZDSS-UHFFFAOYSA-N
- SMILES: O=CC1C=NC(=NC=1)N(C)C(C)C
Computed Properties
- Exact Mass: 179.105862047g/mol
- Monoisotopic Mass: 179.105862047g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 13
- Rotatable Bond Count: 3
- Complexity: 164
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 46.1?2
Experimental Properties
- Density: 1.127±0.06 g/cm3(Predicted)
- Boiling Point: 299.5±32.0 °C(Predicted)
- pka: 2.13±0.10(Predicted)
2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-725625-1.0g |
2-[methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde |
1565477-99-7 | 1g |
$0.0 | 2023-06-07 |
2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde Related Literature
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
Additional information on 2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde
Introduction to 2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde (CAS No. 1565477-99-7)
2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde is a significant compound in the realm of pharmaceutical chemistry, characterized by its unique structural and functional attributes. This heterocyclic aldehyde derivative has garnered considerable attention due to its potential applications in drug discovery and medicinal chemistry. The compound’s molecular framework, featuring a pyrimidine core substituted with a methyl propan-2-yl amino group at the 2-position and a formyl group at the 5-position, positions it as a versatile intermediate in synthetic chemistry. Its chemical formula and structural configuration contribute to its reactivity, making it a valuable building block for the development of novel therapeutic agents.
The CAS No. 1565477-99-7 identifier provides a unique and standardized reference to this chemical entity, facilitating its recognition in scientific literature, patents, and regulatory databases. This alphanumeric code ensures precision in chemical nomenclature and aids in the unambiguous identification of the compound across global research initiatives. The pyrimidine scaffold is particularly noteworthy, as it is a prevalent motif in biologically active molecules, including nucleoside analogs and kinase inhibitors. The presence of the aldehyde functionality further enhances its utility, enabling diverse chemical transformations such as condensation reactions with amines or nucleophiles to yield more complex derivatives.
Recent advancements in medicinal chemistry have highlighted the importance of 2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde as a precursor in the synthesis of small-molecule inhibitors targeting various disease pathways. For instance, studies have demonstrated its role in generating compounds that modulate enzyme activity relevant to cancer metabolism and signal transduction. The compound’s ability to serve as a chiral center or an affinity tag in drug design further underscores its significance. Researchers have leveraged its structural features to develop molecules with enhanced selectivity and reduced toxicity profiles.
In the context of modern drug development, the synthesis of pyrimidine-based aldehydes remains a focal point due to their broad spectrum of biological activities. The methyl(propan-2-yl)amino substituent introduces steric and electronic properties that can fine-tune the pharmacokinetic properties of derived compounds. This modification allows for optimization of solubility, permeability, and metabolic stability—critical parameters for successful drug candidates. Furthermore, computational modeling has been employed to predict the binding modes of these derivatives with biological targets, aiding in rational drug design.
The compound’s reactivity also makes it an attractive candidate for exploring novel synthetic methodologies. Transition-metal-catalyzed reactions, such as cross-coupling and oxidation processes, have been applied to functionalize the pyrimidine ring or introduce additional substituents at specific positions. These strategies enable chemists to generate libraries of analogs efficiently, accelerating the discovery process. Collaborative efforts between academic institutions and pharmaceutical companies have further propelled research into 2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde, fostering innovation in both synthetic chemistry and pharmacological applications.
From a regulatory perspective, the handling and documentation of CAS No. 1565477-99-7 adhere to stringent guidelines to ensure safety and compliance with international standards. While not classified as hazardous under current regulations, proper storage conditions—such as temperature control and moisture exclusion—are recommended to maintain stability during long-term storage or transport. Manufacturers supplying this compound emphasize quality control measures to guarantee batch-to-batch consistency, which is essential for reproducible experimental outcomes.
The intersection of organic synthesis and biochemistry has unlocked new possibilities for utilizing pyrimidine derivatives like 2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde in therapeutic contexts beyond traditional applications. Emerging research suggests potential roles in addressing neurological disorders by modulating neurotransmitter pathways or targeting protein-protein interactions relevant to neurodegeneration. Additionally, its structural similarity to natural nucleobases positions it as a candidate for developing antiviral agents that interfere with viral replication cycles.
As computational power increases and machine learning algorithms become more sophisticated, virtual screening techniques are being employed to identify promising scaffolds derived from this compound class. High-throughput virtual screening (HTVS) enables researchers to evaluate thousands of potential derivatives computationally before proceeding with labor-intensive wet-lab synthesis. This approach not only saves time but also reduces resource consumption by prioritizing molecules with high predicted binding affinities or favorable pharmacokinetic profiles.
The versatility of CAS No. 1565477-99-7 extends beyond academic research; industrial applications are also emerging as pharmaceutical companies seek cost-effective solutions for complex drug syntheses. Process chemists are exploring continuous flow reactors that enhance reaction efficiency while minimizing waste generation—a sustainable approach increasingly favored by industry stakeholders seeking greener alternatives.
In conclusion,2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde represents more than just another chemical entity; it embodies innovation at the forefront of medicinal chemistry research today. Its unique structural features combined with recent advancements in synthetic methodologies ensure continued relevance across multiple disciplines within healthcare science—underscoring why such compounds remain indispensable tools for future breakthroughs.
1565477-99-7 (2-[Methyl(propan-2-yl)amino]pyrimidine-5-carbaldehyde) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)